We have performed a narrative synthesis. A literature search was conducted between January 2000 and June 2014 in 7 databases. The initial search identified 2717 articles; 319 underwent abstract screening, 67 underwent full-text screening, and 25 final articles were included. This review looked at early stage breast cancer in women only, excluding ductal carcinoma in situ and advanced breast cancer. A conceptual framework was created to organize the central constructs underlying women's choices: clinicopathologic factors, physician factors, and individual factors with subgroups of sociodemographic, geographic, and personal beliefs and preferences. This framework guided our review's synthesis and analysis. We found that larger tumor size and increasing stage was associated with increased rates of mastectomy. The results for age varied, but suggested that old and young extremes of diagnostic age were associated with an increased likelihood of mastectomy. Higher socioeconomic status was associated with higher breast conservation therapy (BCT) rates. Resident rural location and increasing distance from radiation treatment facilities were associated with lower rates of BCT. Individual belief factors influencing women's choice of mastectomy (mastectomy being reassuring, avoiding radiation, an expedient treatment) differed from factors influencing choice of BCT (body image and femininity, physician recommendation, survival equivalence, less surgery). Surgeon factors, including female gender, higher case numbers, and individual surgeon practice, were associated with increased BCT rates. The decision-making process for women with early stage breast cancer is complicated and affected by multiple factors. Organizing these factors into central constructs of clinicopathologic, individual, and physician factors may aid health-care professionals to better understand this process.
Background
Breast cancer is the most commonly diagnosed cancer and the second most common cause of cancer death in women in North America. 1 Landmark trials have established that breast conservation therapy (BCT) and mastectomy offer equivalent survival and can be viewed as equivalent treatments in early stage breast cancer (ESBC). [2] [3] [4] [5] With equivalence of treatments, surgery for ESBC is often viewed and described as a preference-sensitive care. 6 Decisionmaking and variations in procedure rates should be ideally owing to underlying patient preferences and values. However, since the seminal National Institute of Health Consensus Conference in 1999 recommended BCT as 'preferable,' 7 there have been ongoing questions and research regarding quality of care as it relates to regional variation in BCT rates for treatment of ESBC. 8 Viewing procedural variation as a result of patient preferences compared with evaluating low BCT rates as a failure of meeting recommendations are dichotomous views. In Canada, there have been significant variations across the country, with mastectomy rates ranging from 26% to 69% between provinces. 9 There has been similarly drastic variations in the United States (US) and the United Kingdom (UK) that are not well-explained.
The choice of mastectomy versus BCT is a complicated decisionmaking process; administrators should look beyond just mastectomy rates and aim to understand the reason behind these variations. The literature trying to identify factors that influence a woman's choice between mastectomy and BCT for treatment of ESBC is heterogeneous in study design, with limited experimental or prospective evidence. No systematic reviews evaluating this topic currently exist in the literature. Mac Bride et al have recently published a nonsystematic review paper highlighting factors associated with therapy choice. 12 They identified some key factors in the literature including patient sociodemographic factors, geographic factors, role of the surgeon, role of reconstruction, and influence of magnetic resonance imaging use. However, this review included studies looking at ductal carcinoma in situ, which is a different disease process. 12 Furthermore, the review did not integrate literature covering other key components in decision-making, including individual patient preference factors and clinicopathologic factors such as tumor size. The aim of this systematic review is to provide a rigorous synthesis of the factors influencing women's choice between mastectomy versus BCT with ESBC.
Methods
Because this review question is complex and underlying factors influencing decision-making are numerous, we have chosen to perform a narrative synthesis as described by Popay. 13 This synthesis method is ideal when there is considerable heterogeneity among the included studies in terms of methods, participants, and a wide array of reported outcomes, as is the case for factors influencing women's choice of mastectomy versus BCT. A systematic review methodology was adopted that allowed inclusion of both quantitative and qualitative papers. Methods adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PRISMA). 14 
Conceptual Framework
In surveying the literature, most research done in this area was conducted in a shotgun approach without a guiding framework. Each study generally only captured small portions of influencing factors without appropriate consideration of the phenomenon as a whole. As a first step to synthesizing the impact of these factors, we created a conceptual framework that illustrates the central constructs underlying women's choices (Figure 1 ). This framework provided a comprehensive basis to guide our review from conduct to the synthesis and analysis. Women's choice of mastectomy versus BCT can be organized into 3 broad influencing constructs: clinicopathologic factors, physician factors, and individual factors, with subgroups of sociodemographic, geographic, and individual belief factors. This framework was developed through integrating previous frameworks, theories, models, literature, and clinical research.
Search Strategy and Information Sources
In collaboration with the team's librarian, a Population, Intervention, Comparison, Outcome (PICO) strategy was adopted to clearly define our research question for a comprehensive literature search. The PICO concepts for the search were breast cancer, mastectomy, breast conservation therapy, and decision-making. Controlled vocabulary and natural language terms were identified for each of the 4 concepts. The terms for the 'breast cancer,' 'mastectomy,' and 'breast conservation therapy' concepts were derived in part from a Cochrane Breast Cancer Group search strategy. 15 An Epoch search strategy was adopted and amended for the term 'decision making.' 16 Our search strategy was peer-reviewed by another librarian, who is experienced in systematic reviews, using Peer Review of Electronic Search Strategies (PRESS). 17 Limits were set for the English language and a date of 2000 to current. This date limit was chosen because BCT was universally accepted as an equivalent treatment to mastectomy by 2000. English language was Duplicate records were removed from the search results, and the records were stored in Refworks bibliographic management tool. Additionally, reference sections of key articles included were reviewed to identify potentially missed articles.
Study Selection
Two primary reviewers (J.G. and G.G.) independently screened all articles in title screening, abstract screening, and full-text screening stages. Standardized forms were created for the review process and an online application, DistillerSR, was used to facilitate the screening process. 18 As part of an inclusive strategy, both reviewers were required to agree on exclusion for the article to be excluded during title screening. When screening abstracts and fulltext articles, all conflicts were flagged for a third expert reviewer to resolve. Articles were included only if they met the following prespecified inclusion criteria: a primary study or review, a full-length article, English text, published from 2000 onwards, a geographic location with culture comparable to North America, looking at simple stage 1 and 2 breast cancer only (ductal carcinoma in situ, stage 3 and 4 cancer, BRCAþ, male breast cancer, and inflammatory breast cancer were excluded), radiation being a standard part of BCT treatment, and the focus of the study was on factors influencing the decision-making of the patient (not decision aids, etc). Specific inclusion and exclusion criteria for each stage of screening were decided and reviewed, in whole, by the systematic review team. The screening questions and forms are attached in Supplemental Appendix 2 (in the online version).
Data Collection
Included studies were grouped into either qualitative or quantitative articles. The 2 researchers performing data extraction (J.G. and a research assistant) both have MDs and were PhD students in epidemiology. This optimized both content knowledge on breast cancer and epidemiology. Data was independently extracted and in duplicate. An online application, Google Drive, was used to facilitate data extraction. A data extraction form was piloted from key references and was modified as further studies were examined. Separate forms were created for univariate data and multivariate data.
Assessment of Bias
Study designs were separated into quantitative studies, qualitative, or mixed-methods studies. For quantitative studies, the NewcastleOttawa Scale (NOS) was the primary tool used for assessment of bias. 19 The use of the NOS has been popular in systematic reviews of nonrandomized studies, and has been regarded as effective and easy to use. 20 Furthermore, this scale considers 3 fundamental domains:
appropriate selection of participants, appropriate measurement of variables, and appropriate control of confounding. 21 In an attempt to mitigate some of the weakness of a single assessment tool, we have chosen to add a summary score of overall quality of study. Two researchers (J.G. and a research assistant) independently evaluated all included quantitative studies in duplicate, and disagreements were resolved through discussion (Table 1) . Qualitative studies were evaluated using a modified version of the Critical Appraisal Skills Programme (CASP) scale, which has been used in qualitative reviews in the past. 22, 23 Two researchers, the lead author (J.G.) and a qualitative expert (L.H.), independently evaluated all qualitative articles in duplicate. Disputes were resolved through discussion (Table 2) .
Synthesis and Analysis
Narrative synthesis was done following methods described by Popay (2006) , 13 and general review principles described by Booth (2012) 24 were followed. The 4 main elements of synthesis described are: (1) developing a theoretical model of how the interventions work, why, and for whom, (2) developing a preliminary synthesis, (3) exploring relationships in the data, and (4) assessing the robustness of the synthesis product. Developing a theoretical model and performing a preliminary synthesis was an iterative process. As previously described, the factors influencing decision-making between mastectomy and BCT are multifactorial, and the literature is heterogeneous. We developed a conceptual framework to guide organization of results for more systematic synthesis and analysis. The 5 constructs in our conceptual model guiding our review are clinicopathologic factors, demographic factors, geographic factors, individual belief factors, and surgeon-related factors. This is illustrated in Figure 1 . All included studies were examined for reported results in any of the key constructs from our framework. Articles were then categorized based on the constructs reported. An article could be placed into multiple categories if it addressed multiple constructs. This resulted in 11 articles reporting clinicopathologic factors, 15 articles reporting the demographic factor age, 7 articles reporting geographic factors, 11 articles reporting individual belief factors, and 10 articles reporting physician-related factors. All articles within each grouping were then individually examined for the reported outcome variables within the construct category. Detailed information regarding each study including method of analysis, predicting variables, outcome, and variable reporting were recorded. This process was carried out through all 5 constructs, and the initial results were summarized. A meta-analysis was originally planned, but owing to the heterogeneity of the reported outcomes, we determined no meaningful metaanalysis could be conducted for any group. Instead, we identified key factors within each construct and performed a narrative synthesis.
There were 3 qualitative studies included in our review. These were reviewed (J.G. and L.H.), and we decided that there was not enough data to perform a meta-analysis or thematic synthesis. These articles fell under the individual belief factors construct and were integrated into the individual belief constructs synthesis and analysis.
Risk of Bias Across Studies
Owing to the level of heterogeneity between studies, assessing risk of bias across studies was not feasible in this review. All given results from included articles were incorporated into our analysis to minimize selective reporting within studies. Figure 2 illustrates our flow diagram. After deduplication, the initial database search identified 1125 articles that underwent title screening. A total of 319 articles moved on to abstract screening, and 67 articles underwent full-text screening, resulting in 25 articles meeting our final inclusion criteria. Of these, 22 articles were quantitative, 3 were qualitative, and 1 was mixed-methods, which was grouped with the quantitative articles.
Results

Study Selection
Study Characteristics
Study characteristics including study design, country of study, sample size, mastectomy rate, BCT rate, and study duration are shown in Table 3 . A total of 274,416 patients were included in the studies. There were 15 studies from the US, 3 from the UK, 2 from Australia, and 1 each from Norway, Austria, and the Netherlands.
Synthesis of Results
Clinicopathologic Factors. Eleven studies looked at clinicopathologic factors. Various factors were examined across studies including, stage, tumor size, nodal status, hormone receptor status, grade, histology, and presence of lymphovascular invasion. Many of these items were addressed in only a few studies and did show a significant impact on choice of mastectomy or BCT. The factors most commonly 
examined in the articles were tumor size and stage (Table 4) , which are closely related in ESBC. These were also the most commonly significant factors. Other clinicopathologic factors examined in multiple studies were grade, hormone receptor status, and tumor histology (Table 5) . Category stratification among these factors varied too greatly to perform a meta-analysis on any of these categories. Studies looking at stage reported decreasing BCT rates with higher stage of cancer. 25 All studies looking at tumor size showed increased rates of mastectomy with a larger tumor size. Roder et al reported that tumors larger than 4 cm were significantly less likely to undergo BCT compared with those less than 3 cm (OR, 1.09; 95% CI, 1.02-1.17). 28 Individual Sociodemographic Factors. Fifteen studies examined sociodemographic factors influence on choice of mastectomy versus BCT. All these studies considered age as potential influencing factor (Table 6 ). Other sociodemographic factors reported in the literature include socioeconomic status (SES), race/ethnicity together or separate, education, marital status, annual income, area deprivation, poverty, body weight, body mass index, employment, and insurance (Table 7 ). Even looking just at age, measures differed significantly throughout the studies, with many considering averages such as means or medians, whereas others used various cutoffs for group comparison from younger and older than 55 years old to 75 years old, or various stratified groupings. There were mixed results for the effect of age on treatment choice. Higher SES was linked to higher rates of BCT. Asian ethnicity was linked to higher rates of mastectomy, black race was linked to higher rates of BCT, and other ethnic groups showed mixed results. For older women, most studies and the studies with better quality data supported increasing age favoring mastectomy. Nine of the studies concluded this, with most studies having good sample sizes, and 6 of the studies utilizing stratified age analysis. In contrast, only 3 studies favored older women choosing BCT, all of which had sample sizes under 400 and used an average age comparison. Locker et al conducted a review of data from the Arimidex, Toxifen, Alone or in Combination trial involving over 9000 patients and found that older age groups were more likely to undergo mastectomy. 29 Compared with women diagnosed under the age of 60, those diagnosed from 60 to 69 years (OR, 1.28; 95% CI, 1.15-1.43), and ! 70 years (OR, 2.22; 95% CI, 1.95-2.52) were more likely to have a mastectomy. In a Surveillance, Epidemiology, and End Results (SEER) database review of 56,000 patients over 64 years old, Hershman et al also found that increasing age was associated with decreasing likelihood of undergoing BCT. 26 Studies measuring race and ethnicity varied in how they captured and grouped their information, but there were trends that Asian/Pacific Islander women were more likely to undergo mastectomy, whereas non-Hispanic black women were more likely to undergo BCT. Two studies reported that, compared with white race, black or non-Hispanic black race was associated with increased rates of BCT (Hershman et Geographic Factors. Seven studies looked at geographic factors influencing mastectomy versus BCT. The variables reported include resident location, travel time or distance to a radiation treatment facility, living distance to bus service, wards with community transport, and distance to surgery center ( Table 8 ). The 2 most commonly examined factors were resident location and travel distance or time to a radiation treatment facility. Although some studies found no difference, most studies showed that rural location and increased distance to a radiation facility were associated with lower rates of BCT. All studies were based in the US, Australia, or the UK. Because the categories and definitions of variables were so mixed, no meta-analysis was possible for geographic factors.
Four studies focused on resident location. In a large US SEER database study looking at over 56,000 patients, Hersman et al found that individuals residing in nonmetropolitan areas were significantly less likely to undergo BCT on both univariate and multivariate analysis (OR, 0.43; 95% CI, 0.40-0.45). 26 Similarly, a large Australian database study conducted by Roder et al found resident remoteness associated with increased rates of mastectomy (relative risk [RR], 1.38; 95% CI, 1.23-1.54). 28 In their multivariate models, compared with major city residence, inner regional (RR, 1.05; 95% CI, 0.99-1.11) and more remote areas (RR, 1.09; 95% CI, 1.00-1.17) were still slightly more likely to undergo mastectomy. In a smaller study, Mastaglia et al also found that women living in rural locations were more likely to choose mastectomy rather than BCT (c 2 , 12.75; P ¼ .00). 38 Cyran et al was the only study looking at resident location that did not find a significant difference between women living in rural or urban areas when it came to rates of mastectomy versus BCT (P ¼ .20).
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The 3 studies looking at living distance to a radiation facility were all travel-focused studies examining related factors that may predict treatment choice. Both Celaya et al 27 and Boscoe et al 35 were USbased studies that found individuals living farther from radiation treatment centers were less likely to undergo BCT. Celeya et al found that women living < 20 miles from a radiation treatment facility were at a decreased likelihood of undergoing BCT compared with women living at 20 to 40 miles (OR, 0.65; 95% CI, 0.53-0.79) and > 60 miles (OR, 0.31; 95% CI, 0.15-0.65). 27 Boscoe et al reported that the likelihood of mastectomy increased monotonically with increasing distances to both the nearest surgical and radiation treatment centers. For distance to a radiation treatment center, the highest increase was found at 75 to 100 km (OR, 1.43; 95% CI, 1.23-1.65). 35 The UK study conducted by Sauzerpf et al found differing results. They found that both distance to a radiation facility and estimated travel time were not predictors of treatment choice. The only exception found was that women living further than 800 m from a public transport service were less likely to undergo BCT. 36 Individual Belief Factors. Eleven studies looked at individual belief factors ( Table 9 ). The majority of studies were survey-based, and 3 of the studies were qualitative. Methodologically, they varied greatly; specifically, in data gathering and analysis. For questionnaires, there were differences in the number of individual factors provided, the wording of these factors, and whether they were rated on Likert scales or ranking lists. The analysis and reporting methods were also diverse, ranging from group comparisons to multivariate modeling. The qualitative studies also had varying methods. Specific methods and primary findings of each study is shown in Table 9 . Overall, the main themes influencing women's choice of mastectomy were mastectomy being the most reassuring option, avoiding radiation, and a more expedient treatment. The main themes influencing women's choice of BCT were body image concerns and femininity, physician recommendation, long-term survival being equivalent, and less surgery being involved. The most common individual belief factors influencing choice of mastectomy can be grouped around the theme of mastectomy being the most reassuring option. This term was reported as fear of recurrence in 6 studies, gaining peace of mind in 1 study, and mastectomy being safer than BCT in 1 study. Schou et al found individuals rating 'fear of cancer recurrence' highly correlated with choice of mastectomy (r s ¼ 0.43; P ¼ .000). 40 Both Temple et al (P ¼ .001) 41 and Molenaar et al (P < .001) 42 found that women who underwent mastectomy rated fear of cancer recurrence significantly higher compared with women who underwent BCT.
Lee et al found those rating 'removing your entire breast to gain peace of mind' were significantly more likely to undergo mastectomy as well (OR, 1.88; 95% CI, 1.60-2.20). 8 In a qualitative study, Caldon et al reported 'most reassuring treatment' as the primary reason women chose mastectomy, further stating that 'many choosing mastectomy said this option reduced their anxiety about the completeness of cancer excision.". 11 In another qualitative study, Killoran et al described 'choosing BCT was inherently a decision based in vanity and was therefore not safe.' 43 The other individual belief factors found to influence mastectomy are avoiding radiation and being a more expedient treatment. Four studies reported 'avoiding radiation' or 'potential side effects of radiotherapy' as a significant factor influencing choice of mastectomy. Lee et al found those rating 'avoiding having radiation' were significantly more likely to undergo mastectomy (OR, 1.23; 95% CI, 1.11-1.36). 8 Two studies reported patients choosing mastectomy because it provided a rapid solution for domestic or employment reasons. 31, 44 McVea et al conducted a qualitative study that reported "their decisions were based primarily on their preference for the option that was more expedient." 44 The most common individual belief factor influencing the choice of BCT was related to body image concerns and femininity. Although potentially distinct, these 2 ideas were often not separated in the literature and often reported together or as connected. The exact terminology used in studies varied greatly, including: 'less disfiguring,' 'physical appearance,' 'appearance better,' 'keeping your breast,' 'local excision less disfiguring,' and 'importance of breast to sexuality.' Temple et al found that women who rated the factor 'importance of breast to sexuality' highly was predictive of choice of BCT (95% CI difference in proportions %, 4.5-32.3; P ¼ .007). 41 This factor was related to 'importance of breasts to feelings of being feminine' in the study. Schou et al found both 'femininity' (r s ¼ 0.26; P ¼ .000) and 'physical appearance' (r s ¼ 0.21; P ¼ .004) correlated with choice of BCT. 40 This was similarly found in a qualitative study by Caldon et al, who reported 'body image concerns predominated among those choosing BCT." 11 Lee et al also found women rating 'keeping your breast' significantly less likely to undergo mastectomy compared with BCT (OR, 0.79; 95% CI, 0.70-0.88). 8 The other individual belief factors that were important for choice of BCT were physician recommendation, long-term survival being equivalent, and less surgery being involved. In a survey by Mastaglia et al, patients rated a list of factors that influenced their treatment decision. 'Knowing my surgeon's preference for the type of surgery' was rated significantly higher for women choosing BCT compared with mastectomy (t ¼ À2.30; P ¼ .023). 38 Nold et al found similar results; the surgeon was significantly more influential in affecting choice of procedure for BCT rather than mastectomy (P < .05). 45 A study by Benedict et al found the most important factor for women's choice of BCT was 'cure rate being equivalent between treatments.' 37 Mastaglia et al found patients choosing BCT rated 'no difference in survival' significantly more important than those who chose mastectomy (t ¼ À3.33; P ¼ .001). 38 This was similarly reported in a qualitative study by McVea et al: 'these women chose BCT reportedly because they felt comfortable with the potential risks of local recurrence, felt more aggressive local therapy was unnecessary.'.
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Physician-related Factors. Nine studies examined how physicianrelated factors influenced patient's choice of mastectomy versus BCT. The variables reported included comparing individual surgeons' rates of BCT, medical oncology consultation, physician treatment recommendation, and specific surgeon demographics such as degree, country of training, gender, or number of procedures. Research design and factors investigated varied throughout the studies (Table 10) . Overall, studies suggested female gender, higher case number, training, and individual surgeon practice were associated with increased BCT rates.
Hersmen et al conducted a large SEER database review with over 56,000 patients; this study looked at the most surgeon-related characteristics. They found increased BCT rates associated with multiple characteristics including being US-trained (OR, There were a few studies to suggest that individual surgeons have varying practices and procedure rates. Reitsamer et al conducted a single center review of 3 specialized high-volume breast surgeons, each with over 50 cases per year. After controlling for patient and tumor factors, compared with surgeon C, both surgeon A (OR, 2.88; 95% CI, 1.48-5.60) and surgeon B (OR, 2.63; 95% CI, 1.34-5.16) were significantly more likely to have patients undergo mastectomy. 30 Temple et al similarly found that an individual surgeon was a predictor of being less likely to undergo BCT (95% CI difference in proportions %, 8.3-55.5; P ¼ .08). 41 Roder et al conducted a large database review in Australia with over 30,000 patients. They found that surgeons with a mean annual breast surgery case load 10 were associated with an increased likelihood of undergoing mastectomy (OR, 1.15; 95% CI, 1.05-1.25). 28 Chagpar et al reviewed a Louisville breast sentinel lymph node study of more than 3000 patients. They found academic affiliation associated with increased BCT rates (OR, 1.193; 95% CI, 1.021-1.393).
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Discussion
The analysis and interpretation of this systematic review utilizes our conceptual framework of why women choose mastectomy versus BCT (Figure 1 ). Each construct was grouped and analyzed separatelyeclinicopathologic factors, physician-related factors, and individual factors with subgroups of sociodemographic factors, geographic factors, and personal belief and preferences factors. The strength of conclusions that can be drawn from each of these constructs differs based on the results.
Among the clinicopathologic factors, larger tumor size, and therefore stage, is the clearest factor that is consistently associated with increased mastectomy rates. This is likely multifactorial in reason. A larger tumor implies a potentially more technically challenging operation, and has been associated with an increased likelihood of requiring a re-excision. 46, 47 Furthermore, increasing tumor size has been associated with increased local recurrence rates. [48] [49] [50] Larger tumor size may also mean a poorer cosmetic outcome. These may all potentially bias the physician towards mastectomy and recommendation against BCT to the patient. Additionally, a larger tumor may influence the patient's perception of the severity of disease, as well as their belief and faith in the effectiveness of BCT. For physician-related factors, we found data supporting female gender, higher case number, training, and individual surgeon practices were associated with increased BCT rates. Variations owing to individual surgeon or surgeon gender certainly raise questions about how surgeons are influencing patient decisionmaking. If variations are because of better facilitation of patients' treatment preferences, then some variation in procedure rates are acceptable. However, if these variations are because of individual physician bias, poor communication styles, or other innate characteristics like empathy and personality, this may reflect a poor standard of cancer care.
The decision-making process between the physician-patient dyad is complicated, and the details of the interaction are difficult to capture. There has recently been increasing research in this area; one popular model being adopted to capture this interaction is the shared decision-making model. 51, 52 This model breaks down the different steps in the treatment decision-making process and the individual roles through each step between physician and patient. In future research, we suggest it is not enough to capture only surgeon demographic characteristics, but it is also necessary to investigate the physician-patient interaction to deepen the understanding of appropriateness and quality of this interaction. Researchers may wish to utilize a model like the shared decision-making model to ground their inquiries. For sociodemographic factors, age was the most prevalent that was reported. As detailed in the results, differing studies drew different conclusions as to how age affected treatment choice. The most consistent results from the literature, with good stratified analysis, seem to suggest that the extremes of diagnostic age are associated with increased likelihood of mastectomy. There have been various explanations hypothesized over how age leads to varying treatment choice. Some have hypothesized that women diagnosed at a young age are choosing mastectomy owing to fear of recurrence; the increasing rates of contralateral prophylactic mastectomy in the young age group seems to support this. [53] [54] [55] Alternatively, women of older age may choose mastectomy for a more expedient treatment, avoiding 6 weeks of radiation, and place less value on the cosmetic outcome as age increases. Another mechanism to explain the influence of age on treatment choice may be to view it as a moderator in the decision-making process for breast cancer instead of the being the main influence underlying treatment choice. For example, a woman may choose mastectomy because of fear of cancer recurrence, and diagnosis at a young age amplifies or increases this patient's fear. Higher SES was repeatedly found to be associated with higher BCT rates. 26, 34 The exact mechanisms causing this disparity is not clear. Is it related to income? Is it life circumstances that limit the individual's abilities to comply with 6 weeks of adjuvant radiation?
There have been studies associating lower SES with later presentation of disease, which may influence both the patient and physician towards choosing mastectomy. 56, 57 These findings raise many questions related to accessibility and quality of care. If patients of low SES groups do not feel supported in their ability to undergo BCT, these hurdles need to be identified so strategies can be put in place to address their needs. Perhaps more time needs to be spent with patients from lower SES groups to explain treatment options and explore availability of local support programs, such as lodging and other social service aids. For geographic factors, most studies suggest that both resident rural location as well as increasing distance from radiation treatment facilities is associated with lower rates of BCT. The obvious conclusion is that because radiation treatment requires daily appointments for 4 to 6 weeks, both travel and/or accommodation may be significant in limiting patients' choice. Furthermore, the potential financial, family, and overall life impact may be more for those living far from treatment locations. Other possible explanations for varying rates would include culture or community influences from rural areas on effectiveness of treatments, or wishing to avoid aspects of treatments such as radiation.
Although individual belief factors may be one of the most important set of factors influencing women's decision-making, it is the most difficult and often least well-studied. To practically capture this information, researchers are required at the minimum to utilize questionnaires or interviews, which is unfortunately impractical and too resource-intensive for large-scale studies. Studies examining individual preferences frequently found women chose mastectomy because it was the most reassuring option, and this was often the most important reason behind their treatment choice. [39] [40] [41] [42] 58 More recent studies have found this belief is complicated and that worry about cancer recurrence was always because of secondary underlying reasonseobserving failed BCT treatments, avoiding follow-up imaging, or family history of breast cancer. 59 The other individual belief factors found to influence choice of mastectomy were avoiding radiation and being a more expedient treatment. As outlined in the results, many of these studies were survey-or interviewbased with relatively small sample sizes. It would be interesting to see in larger scale studies how the incorporation of individual belief factors, such as avoiding radiation, interacted with geographic factors, such as rural location, would affect the impact of each factor on BCT rates. The main themes influencing women's choice of BCT were body image concerns and femininity, physician recommendation, long-term survival being equivalent, and less surgery being involved.
If variations in procedure rates are assumed to be owing to underlying patient values and preferences, why have there been ongoing questions and research 8, 35 regarding quality of care as it relates to regional variation for treatment of ESBC? This stems from the seminal National Institutes of Health Consensus Conference in 1999, which recommended BCT as 'preferable' because it was thought to be less invasive and cosmetically superior. 7 Subsequently, mastectomy rates have been used by health care researchers and policymakers as an indicator of quality of breast cancer care. 60 Researches have frequently cited 'underuse' of BCT 39 and even gone as far as calling BCT the 'standard of care' in some studies. 30 However, viewing procedural variation as a result of patient preferences compared with evaluating low BCT rates as a failure of meeting recommendations are dichotomous views. There has been a recent shift in thinking away from looking at just mastectomy rates and placing more focus on patient-centered care and shared decision-making. 61 With newer research, there is increasing evidence that many patients choose mastectomy for many of their own reasons. As well, some studies have even demonstrated that if physicians recommended a procedure to patients, BCT was usually suggested. Some authors have even suggested that the use of mastectomy rates as a quality indicator may actually bias the physician treatment against patients' wishes. 62 One study found decreased patient satisfaction and physician trust if surgeons attempt to push BCT as the treatment modality to patients who truly preferred mastectomy. 43 With this shift, there is beginning to be more acceptance of higher mastectomy rates if they vary for underlying patient preferences and not other reasons. 63 Within
Canada, this is reflected in the latest 2015 Canadian Partnership Against 64 report, which stated that 'the interprovincial differences do not necessarily reflect differences in the appropriateness of treatment or the quality of care'(p. 82). They further go on to state that there are no formal Canadian performance targets for actual treatment rates.
Conclusions
This review provides a good summary of the factors influencing why patients choose mastectomy versus BCT. By utilizing a conceptual framework, we have organized the numerous factors under broader constructs, which will provide clinicians a logical framework for consideration when counseling patients. We strongly suggest that any future work done in this area should utilize a framework, such as the one we have proposed, to achieve a comprehensive understanding of this complicated topic.
We can conclude from this review that the choice of mastectomy versus BCT is a complicated decision-making process and influenced by many factors. When reviewing ESBC procedure rates, administrators should consider the complexity behind treatment choice. Instead of focusing on just mastectomy rates as a quality of care indicator, there should be a shift in attention to whether patient-centered care and shared decision-making are being achieved. Care teams should ensure patients are making treatment decisions based on informed personal preferences and values.
Additionally, future research can be aimed to identify barriers to appropriate care, such as long travel times and lack of lodging for radiation treatments.
